Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 228.30M | £ 307.70M | £ 280.70M | £ 177.50M | £ 339.60M |
Total Assets | £ 1.75B | £ 1.82B | £ 1.77B | £ 1.64B | £ 1.21B |
Total Debt | £ 0.00 | £ 0.00 | £ 0.00 | £ 278.80M | £ 273.20M |
Net Debt | £ -228.30M | £ -307.70M | £ -280.70M | £ 101.30M | £ -66.40M |
Total Liabilities | £ 1.35B | £ 1.40B | £ 1.34B | £ 1.27B | £ 958.80M |
Stockholders Equity | £ 402.30M | £ 425.80M | £ 428.20M | £ 361.80M | £ 253.20M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |